# Rare Element Resources Ltd: financial statements, quarterly

REEMF · OTC · CIK 1419806 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/reemf.md) · [Financials](/companies/reemf/financials.md) · [Filings](/companies/reemf/filings.md) · [Insiders](/companies/reemf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/reemf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | [0.0](/filings/0001419806-25-000008.md) | [0.0](/filings/0001419806-25-000011.md) | [0.0](/filings/0001419806-25-000019.md) | not reported | [0.0](/filings/0001419806-25-000008.md) | [0.0](/filings/0001419806-25-000011.md) | [0.0](/filings/0001419806-25-000019.md) | [0.0 d](/filings/0001419806-26-000004.md) | [0.0](/filings/0001419806-26-000008.md) | [0.0 d](/filings/0001419806-26-000011.md) |
| Interest expense | $k | [7.0](/filings/0001419806-24-000026.md) | [6.0 d](/filings/0001419806-24-000003.md) | [6.0](/filings/0001419806-24-000010.md) | [9.0](/filings/0001419806-24-000015.md) | [9.0](/filings/0001419806-24-000026.md) | [8.0 d](/filings/0001419806-26-000004.md) | [7.0](/filings/0001419806-26-000008.md) | [6.0](/filings/0001419806-26-000011.md) | [5.0](/filings/0001419806-25-000019.md) | [5.0 d](/filings/0001419806-26-000004.md) | [6.0](/filings/0001419806-26-000008.md) | [5.0](/filings/0001419806-26-000011.md) |
| Net income | $k | [(3,126)](/filings/0001419806-24-000026.md) | [(904) d](/filings/0001419806-25-000004.md) | [(3,626)](/filings/0001419806-25-000008.md) | [(6,179)](/filings/0001419806-25-000011.md) | [(4,734)](/filings/0001419806-25-000019.md) | [(3,912) d](/filings/0001419806-26-000004.md) | [(2,395)](/filings/0001419806-26-000008.md) | [(1,180)](/filings/0001419806-26-000011.md) | [1,106](/filings/0001419806-25-000019.md) | [(2,430) d](/filings/0001419806-26-000004.md) | [(2,133)](/filings/0001419806-26-000008.md) | [(2,758)](/filings/0001419806-26-000011.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001419806-24-000026.md) | not reported | [(0.01)](/filings/0001419806-25-000008.md) | [(0.01)](/filings/0001419806-25-000011.md) | [(0.01)](/filings/0001419806-25-000019.md) | not reported | [0.00](/filings/0001419806-26-000008.md) | [0.00](/filings/0001419806-26-000011.md) | [0.00](/filings/0001419806-25-000019.md) | not reported | [0.00](/filings/0001419806-26-000008.md) | [0.00](/filings/0001419806-26-000011.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001419806-24-000026.md) | not reported | [(0.01)](/filings/0001419806-25-000008.md) | [(0.01)](/filings/0001419806-25-000011.md) | [(0.01)](/filings/0001419806-25-000019.md) | not reported | [0.00](/filings/0001419806-26-000008.md) | [0.00](/filings/0001419806-26-000011.md) | [0.00](/filings/0001419806-25-000019.md) | not reported | [0.00](/filings/0001419806-26-000008.md) | [0.00](/filings/0001419806-26-000011.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.6](/filings/0001419806-24-000026.md) | [3.6](/filings/0001419806-25-000004.md) | [38.1](/filings/0001419806-25-000008.md) | [30.6](/filings/0001419806-25-000011.md) | [29.7](/filings/0001419806-25-000019.md) | [26.7](/filings/0001419806-26-000004.md) | [24.4](/filings/0001419806-26-000008.md) | [23.1](/filings/0001419806-26-000011.md) | [21.7](/filings/0001419806-25-000019.md) | [19.3](/filings/0001419806-26-000011.md) | [47.1](/filings/0001419806-26-000008.md) | [26.8](/filings/0001419806-26-000011.md) |
| Current assets | $m | [10.5](/filings/0001419806-23-000036.md) | [9.8](/filings/0001419806-25-000004.md) | [41.6](/filings/0001419806-24-000010.md) | [35.2](/filings/0001419806-24-000015.md) | [32.1](/filings/0001419806-24-000026.md) | [26.9](/filings/0001419806-26-000004.md) | [24.6](/filings/0001419806-25-000008.md) | [23.2](/filings/0001419806-25-000011.md) | [23.6](/filings/0001419806-25-000019.md) | [21.2](/filings/0001419806-26-000011.md) | [49.7](/filings/0001419806-26-000008.md) | [31.6](/filings/0001419806-26-000011.md) |
| Total assets | $m | [11.5](/filings/0001419806-23-000036.md) | [10.7](/filings/0001419806-25-000004.md) | [42.7](/filings/0001419806-24-000010.md) | [36.4](/filings/0001419806-24-000015.md) | [33.3](/filings/0001419806-24-000026.md) | [29.7](/filings/0001419806-26-000004.md) | [27.3](/filings/0001419806-25-000008.md) | [26.0](/filings/0001419806-25-000011.md) | [26.4](/filings/0001419806-25-000019.md) | [24.1](/filings/0001419806-26-000011.md) | [52.6](/filings/0001419806-26-000008.md) | [49.6](/filings/0001419806-26-000011.md) |
| Current liabilities | $m | [0.3](/filings/0001419806-23-000036.md) | [1.9](/filings/0001419806-25-000004.md) | [2.1](/filings/0001419806-24-000010.md) | [2.1](/filings/0001419806-24-000015.md) | [3.7](/filings/0001419806-24-000026.md) | [2.1](/filings/0001419806-26-000004.md) | [2.2](/filings/0001419806-25-000008.md) | [2.1](/filings/0001419806-25-000011.md) | [1.4](/filings/0001419806-25-000019.md) | [1.5](/filings/0001419806-26-000011.md) | [1.6](/filings/0001419806-26-000008.md) | [1.4](/filings/0001419806-26-000011.md) |
| Total liabilities | $m | [2.2](/filings/0001419806-23-000036.md) | [2.3](/filings/0001419806-25-000004.md) | [2.6](/filings/0001419806-24-000010.md) | [2.5](/filings/0001419806-24-000015.md) | [4.1](/filings/0001419806-24-000026.md) | [2.5](/filings/0001419806-26-000004.md) | [2.5](/filings/0001419806-25-000008.md) | [2.4](/filings/0001419806-25-000011.md) | [1.7](/filings/0001419806-25-000019.md) | [1.8](/filings/0001419806-26-000011.md) | [1.9](/filings/0001419806-26-000008.md) | [1.7](/filings/0001419806-26-000011.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [9.3](/filings/0001419806-24-000026.md) | [8.4](/filings/0001419806-26-000004.md) | [40.1](/filings/0001419806-25-000011.md) | [33.9](/filings/0001419806-25-000019.md) | [29.1](/filings/0001419806-25-000019.md) | [27.2](/filings/0001419806-26-000011.md) | [24.8](/filings/0001419806-26-000011.md) | [23.6](/filings/0001419806-26-000011.md) | [24.7](/filings/0001419806-25-000019.md) | [22.3](/filings/0001419806-26-000011.md) | [50.7](/filings/0001419806-26-000011.md) | [48.0](/filings/0001419806-26-000011.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(4,694) d](/filings/0001419806-24-000026.md) | [(2,940) d](/filings/0001419806-25-000004.md) | [(784)](/filings/0001419806-25-000008.md) | [(7,503) d](/filings/0001419806-25-000011.md) | [(890) d](/filings/0001419806-25-000019.md) | [(1,442) d](/filings/0001419806-26-000004.md) | [(2,269)](/filings/0001419806-26-000008.md) | [(1,268) d](/filings/0001419806-26-000011.md) | [(1,320) d](/filings/0001419806-25-000019.md) | [(2,264) d](/filings/0001419806-26-000004.md) | [(2,725)](/filings/0001419806-26-000008.md) | [(3,466) d](/filings/0001419806-26-000011.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001419806-24-000026.md) | [0.0 d](/filings/0001419806-24-000003.md) | not reported | not reported | [0.0 d](/filings/0001419806-24-000026.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [212](/filings/0001419806-23-000036.md) | [257](/filings/0001419806-24-000010.md) | [257](/filings/0001419806-24-000015.md) | [257](/filings/0001419806-24-000026.md) | [320](/filings/0001419806-25-000008.md) | [439](/filings/0001419806-25-000011.md) | [511](/filings/0001419806-25-000019.md) | [587](/filings/0001419806-26-000008.md) | [587](/filings/0001419806-26-000011.md) | [517](/filings/0001419806-25-000019.md) | [624](/filings/0001419806-26-000008.md) | [624](/filings/0001419806-26-000011.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 645,368,390 at 2026-08-03, from the cover of the [10-Q filed 2026-08-04](/filings/0001419806-26-000011.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.